Kaplan-Meier estimates in the clinicopathological factors revealed that patients with high expression of HJURP had significantly reduced cancer-specific survival rates compared to those with low HJURP expression (log-rank test; p = 0.016), as shown in Figure 2. Here, HJURP is linked to cancer.